HLF and NFIL3 have been shown to have important regulatory functions in a number of solid tumors as reviewed in Ahmadi et al. [57] with a role in promoting ferroptosis resistance in triple-negative breast cancer [58]. Here, HLF is linked to triple-negative breast carcinoma.